LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 50 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293,123 | +17.9% | 327,373 | -6.6% | 0.40% | +34.0% |
| Q2 2023 | $1,096,667 | +2.2% | 350,373 | +47.9% | 0.30% | -6.8% |
| Q1 2023 | $1,073,035 | -45.1% | 236,873 | -49.9% | 0.32% | -41.5% |
| Q4 2022 | $1,954,052 | +6.2% | 473,136 | -17.7% | 0.55% | +11.1% |
| Q3 2022 | $1,840,000 | +1777.6% | 574,996 | +1050.1% | 0.50% | +1733.3% |
| Q2 2022 | $98,000 | -51.5% | 49,996 | 0.0% | 0.03% | -49.1% |
| Q1 2022 | $202,000 | -73.3% | 49,996 | -28.8% | 0.05% | -72.1% |
| Q4 2021 | $757,000 | +1.7% | 70,177 | +8.8% | 0.19% | -3.6% |
| Q3 2021 | $744,000 | -1.6% | 64,487 | -16.2% | 0.20% | +24.7% |
| Q2 2021 | $756,000 | -36.5% | 76,987 | -5.5% | 0.16% | -44.0% |
| Q1 2021 | $1,190,000 | +14.8% | 81,432 | +68.2% | 0.28% | -8.7% |
| Q4 2020 | $1,037,000 | -13.7% | 48,428 | -38.8% | 0.31% | -20.8% |
| Q3 2020 | $1,201,000 | -26.0% | 79,155 | -37.3% | 0.39% | -16.7% |
| Q2 2020 | $1,622,000 | – | 126,261 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
| Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
| GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
| DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
| Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
| Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
| Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |